Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.8440
-0.0499 (-5.58%)
At close: Aug 21, 2025, 4:00 PM
0.8600
+0.0160 (1.90%)
After-hours: Aug 21, 2025, 6:33 PM EDT
Cytosorbents Stock Forecast
Stock Price Forecast
The 2 analysts that cover Cytosorbents stock have a consensus rating of "Buy" and an average price target of $5.50, which forecasts a 551.66% increase in the stock price over the next year. The lowest target is $1.00 and the highest is $10.
Price Target: $5.50 (+551.66%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Cytosorbents stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +1,084.83% | Aug 20, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +1,084.83% | Aug 8, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +1,084.83% | Jul 21, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +1,084.83% | Jun 25, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +1,084.83% | May 15, 2025 |
Financial Forecast
Revenue This Year
39.56M
from 35.59M
Increased by 11.15%
Revenue Next Year
48.02M
from 39.56M
Increased by 21.39%
EPS This Year
-0.16
from -0.38
EPS Next Year
-0.09
from -0.16
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 41.8M | 55.9M | 74.6M | ||
| Avg | 39.6M | 48.0M | 62.8M | ||
| Low | 36.3M | 40.9M | 51.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 17.5% | 41.4% | 55.3% | ||
| Avg | 11.1% | 21.4% | 30.8% | ||
| Low | 1.9% | 3.3% | 6.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.07 | 0.05 | 0.22 |
| Avg | -0.16 | -0.09 | 0.04 |
| Low | -0.21 | -0.20 | -0.14 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.